As your physician, I monitor for side effects, nutrient deficiencies, and changes in muscle or bone mass
It is the sole responsibility of the purchaser to use materials in accordance with all applicable laws, safety protocols, and ethical standards
Current methods fall short because: Viability data alone cant distinguish a healthy cell from a metabolically impaired one Metabolic readouts often require specialized instruments or complex sample prep Connecting viability screening with downstream metabolic profiling usually means separate assays and separate workflows Questions & Solutions How are my cells using glucose
Staresinic M et al
A study in July 2024 by researchers at Mass Eye and Ear in Boston found that people taking semaglutide for type 2 diabetes or weight loss had a higher risk of developing nonarteritic anterior ischemic optic neuropathy, an eye condition that can cause blindness, than people taking medications other than GLP-1 drugs for diabetes or obesity
Carter BZ, Mak PY, Mu H, Mak DH, Dettman EJ, Cardone M, Wang X, Schober W, Tao W, Seki T, Andreeff M